SLC6A4: Sodium-dependent serotonin transporter
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Serotonin transporter that cotransports serotonin with one Na(+) ion in exchange for one K(+) ion and possibly one proton in an overall electroneutral transport cycle.
- Drugs that act on it: 30
- With a US drug page: 20
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Amitriptyline | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Amoxapine | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Chlorphentermine | Approved | Serotonin transporter substrate | Substrate | Withdrawn |
| Citalopram | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Clomipramine | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Duloxetine | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Escitalopram | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Fluoxetine | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Fluvoxamine | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Imipramine | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Levomilnacipran | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Lumateperone | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Milnacipran | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Nefazodone | Approved | Serotonin transporter inhibitor | Inhibitor | WithdrawnBoxed warning |
| Nortriptyline | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Protriptyline | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Sertraline | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Trazodone | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Vilazodone | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Vortioxetine | Approved | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Dapoxetine | — | Serotonin transporter inhibitor | Inhibitor | — |
| Desvenlafaxine | — | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Dothiepin | — | Serotonin transporter inhibitor | Inhibitor | — |
| Faxeladol | — | Serotonin transporter inhibitor | Inhibitor | — |
| GSK163090 | — | Serotonin transporter antagonist | Antagonist | — |
| Indalpine | — | Serotonin transporter inhibitor | Inhibitor | Withdrawn |
| Midomafetamine | — | Sodium-dependent serotonin transporter releasing agent | Releasing agent | — |
| Paroxetine | — | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
| Tedatioxetine | — | Serotonin transporter inhibitor | Inhibitor | — |
| Venlafaxine | — | Serotonin transporter inhibitor | Inhibitor | Boxed warning |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Fibromyalgia
- 0.61
- Panic disorder
- 0.60
- Anxiety disorder
- 0.60
- Obesity disorder
- 0.59
- Social phobia
- 0.59
- Bipolar disorder
- 0.58
- Generalized anxiety disorder
- 0.57
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- SLC6A4
- Related
- Monoamine transporter
Drugs and mechanisms are from ChEMBL CHEMBL228 (CC BY-SA 3.0). Gene name, function (UniProt P31645, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets